Health Canada issues advisory on potential Pulmicort Turbuhaler device failure

Health Canada has issued an advisory to health care professionals that “AstraZeneca Canada has received a small number of product complaints for Pulmicort Turbuhaler, 200 µg per metered dose (200 doses) regarding the malfunction of the delivery device that results in a failure to dispense the dose of medication.” According to the notice, the devices sometimes fail to load a dose.

The agency reminds clinicians to tell patients to listen for a click indicating proper loading of the dose after they twist the grip on the device before inhalation.

Read the Health Canada/AstraZeneca notice.

Share

published on

June 10SMI.London 2026, London, UK

July 13-July 162026 ISAM Congress, Taipei, Taiwan

September 15-September 18DDL New Researcher Network Summer Event, London, UK

September 16-September 17IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA